Picture of Nanogroup SA logo

NNG Nanogroup SA Share Price

0.000.00%
pl flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Momentum

Relative Strength (%)
1m-0.21%
3m-6.51%
6m-7.22%
1yr-33.98%
Volume Change (%)
10d/3m-50.5%
Price vs... (%)
52w High-33.52%
50d MA+0.82%
200d MA-6.8%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-4.34%
Return on Equity-13.48%
Operating Margin-562.23%

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202331st Dec 2024
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2023 / 2024

Blurred out image of Nanogroup SA EPS forecast chart

Profile Summary

Nanogroup SA is a Poland-based company engaged in the biotechnology sector. The Company focuses on the investment in, as well as development of advanced biotechnological projects in the areas of cancer prevention, early diagnosis, targeted cancer therapies and ontological rehabilitation. Its projects portfolio includes NanoVelos, which is responsible for the creation of drug delivery system for proven oncologic medicines to optimize their performance; NanoSanguis, which develops artificial blood to keep alive patients wounded in accidents, as well as a system, named Organ farm, to preserve human organs ex vivo, and NanoThea, which is dedicated to technology that detects cancer cells in early stage.

Directors

Last Annual
December 31st, 2022
Last Interim
September 30th, 2023
Incorporated
December 2nd, 2016
Public Since
December 21st, 2017
Sector
Biotechnology & Medical Research
Industry
Healthcare
Exchange
pl flag iconWarsaw Stock Exchange
Shares in Issue
20,097,459
Blurred out image of a map
Address
Ul. Rakowiecka 36, WARSZAWA, 02-532
Web
https://nanogroup.eu/
Phone
Auditors
GLOBAL AUDIT PARTNER Sp. z o.o.

NNG Share Price Performance

Upcoming Events for NNG

Similar to NNG

Picture of Airway Medix SA logo

Airway Medix SA

pl flag iconWarsaw Stock Exchange

Picture of Bioton SA logo

Bioton SA

pl flag iconWarsaw Stock Exchange

Picture of Braster SA logo

Braster SA

pl flag iconWarsaw Stock Exchange

Picture of Captor Therapeutics SA logo

Captor Therapeutics SA

pl flag iconWarsaw Stock Exchange

Picture of E-Shopping SA logo

E-Shopping SA

pl flag iconWarsaw Stock Exchange

FAQ